Boothbay Fund Management, LLC Ligand Pharmaceuticals Inc Transaction History

Boothbay Fund Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$127.69 - $165.85 $2.42 Million - $3.14 Million	-18,941 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$102.33 - $144.73 $865,609 - $1.22 Million	-8,459 Reduced 30.87%	18,941 $2.64 Million
Q2 2021 Aug 16, 2021	BUY	$113.03 - $155.64 $1.97 Million - $2.71 Million	17,400 Added 174.0%	27,400 $3.6 Million
Q1 2021 May 17, 2021	BUY	$99.52 - $215.83 $995,200 - $2.16 Million	10,000 New	10,000 $1.53 Million
Q2 2019 Aug 14, 2019	SELL	$107.38 - $129.34 $831,228 - $1 Million	-7,741 Closed	0 $0

Q1 2019 May 15, 2019	BUY	$105.93 - $142.47 $820,004 - $1.1 Million	7,741 New	7,741 $973,000

233

16.5M

77.9K

25K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.4B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.